Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03970525 · ClinicalTrials.gov registry record
Venturi and Peristaltic Based Phacoemulsification in Femtosecond Laser Cataract Surgery
A clinical trial of Cataract Senile, sponsored by Wendell Scott.
- Completed
- Registry status
- 111
- Enrollment target
- 1
- Study location
NCT03970525: Completed study of Cataract Senile, sponsored by Wendell Scott.
NCT03970525 is a study of Cataract Senile that has completed, run by Wendell Scott. The registered enrollment target is 111 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03970525, a study of Cataract Senile, has completed, sponsored by Wendell Scott.
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare two methods of vacuum (peristaltic or venturi) commonly used during the removal of a femtosecond treated cataract. The investigators will observe which method uses less energy, is gentler on the eye, reduces corneal swelling and if the vision recovers faster with one method compared to the other.
Primary Outcome
Phaco EFX (the effective phaco time with a specific coefficient for the transversal movement of the phaco tip- expressed in seconds.)
Conditions Studied
Interventions
- DEVICE Venturi pump
- DEVICE Peristaltic vacuum pump
Study Locations (1)
Missouri
- Mercy Clinic Eye specialists - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2019-05-16 |
| Est. Completion | 2023-03-29 |
What the finished NCT03970525 record still lists
NCT03970525 is an observational study that tracks outcomes without assigning an intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Cataract Senile appearing as the primary indexed condition, and to 2 interventions - of which Venturi pump is the first listed.
NCT03970525 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03970525 about?
NCT03970525 is a clinical study titled "Venturi and Peristaltic Based Phacoemulsification in Femtosecond Laser Cataract Surgery". This study will compare two methods of vacuum (peristaltic or venturi) commonly used during the removal of a femtosecond treated cataract. The investigators will observe which method uses less energy, is gentler on the eye, reduces corneal swelling and if the vision recovers faster with one method c...
What is the current status of trial NCT03970525?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2019-05-16. Estimated completion is 2023-03-29.
What conditions does trial NCT03970525 study?
This clinical trial studies the following conditions: Cataract Senile.
What interventions are being tested in trial NCT03970525?
The interventions under investigation include: Venturi pump (DEVICE), Peristaltic vacuum pump (DEVICE).
Who is sponsoring clinical trial NCT03970525?
This trial is sponsored by Wendell Scott, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03970525 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract Senile
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI